Gossamer Bio (GOSS) EV to FCF (2019 - 2026)
Gossamer Bio (GOSS) posted EV to FCF of 0.15 for Q2 2026, down 73.72% on a QoQ basis from 0.56 in Q1 2026, and up 110.44% year-over-year from 0.07 in Q2 2025.
Analysis
Gossamer Bio (GOSS) EV to FCF (2019 - 2026) Analysis & Trends
Gossamer Bio has reported EV to FCF for 8 years, with the latest figure at 0.15 in Q2 2026.
- On a quarterly basis, EV to FCF rose 110.44% year-over-year to 0.15 in Q2 2026; TTM through Jun 2026 was 0.04, a 108.29% increase from a year earlier, with the FY2025 full-year figure at 3.43, down 113.13% from the prior year.
- EV to FCF was 0.15 for Q2 2026 at Gossamer Bio, down from 0.56 in the prior quarter.
- The five-year high for EV to FCF was 4.71 in Q4 2023, with the low at 22.16 in Q3 2022.
- Average EV to FCF over 5 years is 2.55, with a median of 0.17 recorded in 2025.
- The sharpest annual moves came in 2023 and 2025: EV to FCF jumped 343.98% in 2023, then slumped 576.32% in 2025.
- Over 5 years, EV to FCF stood at 1.06 in 2022, then jumped by 343.98% to 4.71 in 2023, then sank by 45.84% to 2.55 in 2024, then plunged by 576.32% to 12.16 in 2025, then soared by 101.21% to 0.15 in 2026.
- The last three EV to FCF figures came in at 0.15 (Q2 2026), 0.56 (Q1 2026), and 12.16 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
| 10 | Gossamer Bio | 57.60 Mn | 576,568.19 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.15 |
| Mar 31, 2026 | 0.56 |
| Dec 31, 2025 | -12.16 |
| Sep 30, 2025 | -11.84 |
| Jun 30, 2025 | -1.42 |
| Mar 31, 2025 | 0.20 |
| Dec 31, 2024 | 2.55 |
| Sep 30, 2024 | 3.21 |
| Jun 30, 2024 | -1.30 |
| Mar 31, 2024 | -0.43 |
| Dec 31, 2023 | 4.71 |
| Sep 30, 2023 | 4.11 |
| Jun 30, 2023 | 1.24 |
| Mar 31, 2023 | 1.54 |
| Dec 31, 2022 | 1.06 |
| Sep 30, 2022 | -22.16 |
| Jun 30, 2022 | -8.58 |
| Mar 31, 2022 | -7.32 |
| Dec 31, 2021 | -13.09 |
| Sep 30, 2021 | -13.64 |